|
VYNE Vyne Therapeutics Inc 1566044 |
| Balance Sheet |
|
Current Assets
|
$25,789,000.00 |
|
Assets
|
$25,873,000.00 |
|
Current Liabilities
|
$1,236,000.00 |
|
Liabilities
|
$1,236,000.00 |
|
Equity
|
$24,637,000.00 |
|
Shares Out
|
33352858.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,081,000.00 |
|
Investing Cash Flow
|
$4,700,000.00 |
| Market Analysis |
Market Cap
|
$30,684,629.36 |
|
Price
|
$0.92 |
|
BVPS
|
0.74 |
|
PB
|
1.24 |
|
EPS
|
-0.08 |
|
PS
|
65.93 |
|
FCF
|
$-4,081,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:42 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VYNE documents filed with the SEC.
VYNE Filings
Clear
